BamSEC and AlphaSense Join Forces
Learn More

Astria Therapeutics Inc.

NASDAQ: ATXS    
Share price (1/8/25): $8.35    
Market cap (1/8/25): $471 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Other Revised 03/25/24 Astria Therapeutics, Inc. - Special Call 03/25/24
CY 2023
Earnings Revised 11/13/23 Astria Therapeutics, Inc., Q3 2023 Earnings Call, Nov 13, 2023 11/13/23 Other Revised 10/12/23 Astria Therapeutics, Inc. - Special Call 10/12/23 Earnings Revised 03/22/23 Astria Therapeutics, Inc., Q4 2022 Earnings Call, Mar 22, 2023 03/22/23
CY 2022
Other Revised 12/15/22 Astria Therapeutics, Inc. - Special Call 12/15/22
CY 2021
Earnings Revised 11/10/21 Astria Therapeutics, Inc., Q3 2021 Earnings Call, Nov 10, 2021 11/10/21 Other Revised 06/02/21 Catabasis Pharmaceuticals, Inc. - Shareholder/Analyst Call 06/02/21 Other Revised 01/29/21 Catabasis Pharmaceuticals, Inc., Quellis Biosciences, Inc. - M&A Call 01/29/21
CY 2020
Other Revised 09/11/20 Catabasis Pharmaceuticals, Inc. - Special Call 09/11/20 Earnings Revised 03/10/20 Catabasis Pharmaceuticals, Inc., Q4 2019 Earnings Call, Mar 10, 2020 03/10/20
CY 2019
Earnings Revised 11/07/19 Catabasis Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 07, 2019 11/07/19 Earnings Revised 08/08/19 Catabasis Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019 08/08/19 Earnings Revised 03/12/24 Catabasis Pharmaceuticals, Inc., Q1 2019 Earnings Call, May 14, 2019 05/14/19 Earnings Revised 03/14/19 Catabasis Pharmaceuticals, Inc., Q4 2018 Earnings Call, Mar 14, 2019 03/14/19
CY 2018
Earnings Revised 11/13/18 Catabasis Pharmaceuticals, Inc., Q3 2018 Earnings Call, Nov 13, 2018 11/13/18 Earnings Revised 08/09/18 Catabasis Pharmaceuticals, Inc., Q2 2018 Earnings Call, Aug 09, 2018 08/09/18
CY 2017
Earnings Revised 08/10/17 Catabasis Pharmaceuticals, Inc., Q2 2017 Earnings Call, Aug 10, 2017 08/10/17